Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Chen-Teng Wu"'
Autor:
Meng-Xia Su, Hsiang-Wen Lin, Hanh T. H. Nguyen, Tien-Chao Lin, Chih-Jung Chen, Hwei-Chung Wang, Chen-Teng Wu, Yao-Chung Wu, Geng-Yan He, Liang-Chih Liu, Chih-Hao Huang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Studies have shown that the absolute lymphocyte count (ALC) and the neutrophil-to-lymphocyte ratio (NLR) are related to the outcomes in patients with breast cancer receiving specific chemotherapies. However, the reports have focus
Externí odkaz:
https://doaj.org/article/f97469a6d895400aa394684af461c007
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Pulmonary fibrosis features in damaged pulmonary structure or over-produced extracellular matrix and impaired lung function, leading to respiratory failure and eventually death. Fibrotic lungs are characterized by the secretion of pro-fib
Externí odkaz:
https://doaj.org/article/bb17719baa3247afb27b3a7064ae15e3
Autor:
Yen-Chang Chen, Chen-Teng Wu, Jia-Hong Chen, Cheng-Fang Tsai, Chen-Yun Wu, Pei-Chun Chang, Wei-Lan Yeh
Publikováno v:
Oncogenesis, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Migration and metastasis commonly happen to triple-negative breast cancer (TNBC) patients with advanced diseases. In many studies, it has been suggested that epithelial-mesenchymal transition (EMT) is one of the key mechanisms triggering can
Externí odkaz:
https://doaj.org/article/76922b2bdf0b42238f90a7e4f591f3c7
Autor:
Chih-Jung Chen, Chen-Teng Wu, Yu-Fen Chen, Hsiang-Wen Lin, Chen-Yuan Lin, Tzu-Pei Yeh, Tien-Chao Lin, Wan-Chen Yeh, Lin-Chun Yang, Yu-Chieh Chen, Li-Ying Chiu, Hwei-Chung Wang, Yao-Chung Wu, Liang-Chih Liu
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Objectives This study aimed to compare the time required and concerns raised by various perspectives of participants regarding administering subcutaneous and intravenous trastuzumab for patients with breast cancer (BC).Design This observational time
Externí odkaz:
https://doaj.org/article/e82e742d13fc469c9674c4b6d937697b
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
Background and aimDuring the COVID-19 pandemic, an Internet-Mindfulness-Based Stress Reduction (iMBSR) program was delivered and may be better than an in-person approach. Our study evaluated the effects of iMBSR intervention on mental health, self-ef
Externí odkaz:
https://doaj.org/article/0f0f6366b139476fbdecef5c85dd230e
Autor:
Yen-Chang Chen, Jia-Hong Chen, Cheng-Fang Tsai, Chen-Teng Wu, Miao-Hsiang Wu, Pei-Chun Chang, Wei-Lan Yeh
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Metastasis represents an advanced stage of cancers, and matrix metalloproteinases are critical regulators. Calcium signal is crucial for appropriate cell behaviors. The efficacy and effects of calcium channel blockers in treating cancers
Externí odkaz:
https://doaj.org/article/7c917c12d8894107925d37d57de352f0
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Leptin is considered a tumorigenic adipokine, suggested to promote tumorigenesis and progression in many cancers. On the other hand, intercellular adhesion molecule-1 (ICAM-1) shows altered expression in a variety of benign and malignant
Externí odkaz:
https://doaj.org/article/55ea5fb51ef747d38c820922b8685faa
Publikováno v:
Journal of Functional Foods, Vol 5, Iss 3, Pp 1414-1420 (2013)
Methotrexate (MTX) is an important immunosuppressant with narrow therapeutic window. The transport of MTX was associated with multi-drug resistance proteins (MRPs) and breast cancer resistance protein (BCRP). Noni fruit is a phenolics rich health foo
Externí odkaz:
https://doaj.org/article/61d207beab534450876e018efdc48e8f
Autor:
Hsiang-Wen Lin, Chen-Yuan Lin, Tzu-Pei Yeh, Tien-Chao Lin, Wan-Chen Yeh, Lin-Chun Yang, Yu-Chieh Chen, Li-Ying Chiu, Chen-Teng Wu, Chih-Jung Chen, Yu-Fen Chen, Hwei-Chung Wang, Yao-Chung Wu, Liang-Chih Liu
Publikováno v:
BMJ Open. 13:e059288
ObjectivesThis study aimed to compare the time required and concerns raised by various perspectives of participants regarding administering subcutaneous and intravenous trastuzumab for patients with breast cancer (BC).DesignThis observational time–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1c85c7ad14881c0663aba0766f4706
https://doi.org/10.1136/bmjopen-2021-059288
https://doi.org/10.1136/bmjopen-2021-059288
Autor:
Chih-Jung Chen, Hanh T.H. Nguyen, Chih-Hao Huang, Hwei-Chung Wang, Chen-Teng Wu, Yao-Chung Wu, Geng-Yan He, Chiahung Chou, Hsiang-Wen Lin, Liang-Chih Liu
Publikováno v:
Chemotherapy.
Background: This study aimed to examine the effectiveness and safety of eribulin used as an early-line (EL, i.e., first-/second-line) versus late-line (LL, i.e., third-line and beyond) chemotherapy for recurrent advanced or metastatic breast cancer (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6619890921c3f234cb4df27c0000e6b8
https://pubmed.ncbi.nlm.nih.gov/36108618
https://pubmed.ncbi.nlm.nih.gov/36108618